CDX · ASX

CardieX Limited (ASX:CDX)

AU$0.051

 0.0 (0.0%)
ASX:Live
08/05/2025 12:00:00 AM
Near Support HALO Ords GROWTH AUS Big Candle All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CDX Overview

CDX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About CDX

Website

N/A

Telephone

61.2.9874.8761

Address

Suite 301 55 Lime Street Sydney, New South Wales (NSW) 2000

Description

CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment includes pharmaceutical trials business. The Europe segment focuses on the Middle East and Africa. The Asia Pacific segment is involved in the operations of Asia, Australia, and New Zealand. The company was founded by Ross Harricks, Niall Charles Edgar Cairns, Craig R. Cooper, and Michael Francis O'Rourke in 1994 and is headquartered in Sydney, Australia.

CDX Price Chart

Key Stats

Market Cap

AU$20.67M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.17

Trade Value (12mth)

AU$5,707.00

1 week

-5.56%

1 month

-17.74%

YTD

-48.48%

1 year

0%

All time high

7.82

Key Fundamentals

EPS 3 yr Growth

-36.50%

EBITDA Margin

-57.90%

Operating Cashflow

-$8m

Free Cash Flow Return

-359.30%

ROIC

-314.80%

Interest Coverage

-5.30

Quick Ratio

1.00

Other Data

Shares on Issue (Fully Dilluted)

296m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CDX Announcements

Latest Announcements

Date Announcements

06 May 25

Lodgement of CONNEQT Pulse Device with the TGA

×

Lodgement of CONNEQT Pulse Device with the TGA

30 April 25

March Quarterly Appendix 4C

×

March Quarterly Appendix 4C

30 April 25

March Quarterly Activities Report

×

March Quarterly Activities Report

09 April 25

Notice of Extraordinary General Meeting/Proxy Form

×

Notice of Extraordinary General Meeting/Proxy Form

01 April 25

CONNEQT Launches Apple Health Integration on iPhone

×

CONNEQT Launches Apple Health Integration on iPhone

25 March 25

Launch of New Cardiology Report Feature in CONNEQT App

×

Launch of New Cardiology Report Feature in CONNEQT App

28 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

17 February 25

Response to ASX Price Query Letter

×

Response to ASX Price Query Letter

31 January 25

December Quarterly Appendix 4C

×

December Quarterly Appendix 4C

31 January 25

December Quarterly Activities Report

×

December Quarterly Activities Report

23 January 25

CONNEQT App Launches in USA as Pulse Deliveries Commence

×

CONNEQT App Launches in USA as Pulse Deliveries Commence

02 January 25

Change in substantial holding

×

Change in substantial holding

31 December 24

Appendix 3Y x4

×

Appendix 3Y x4

31 December 24

Change in substantial holding

×

Change in substantial holding

30 December 24

Application for quotation of securities - CDX

×

Application for quotation of securities - CDX

30 December 24

Becoming a substantial holder

×

Becoming a substantial holder

24 December 24

Proposed issue of securities - CDX

×

Proposed issue of securities - CDX

24 December 24

Application for quotation of securities - CDX

×

Application for quotation of securities - CDX

24 December 24

Application for quotation of securities - CDX

×

Application for quotation of securities - CDX

20 December 24

Cleansing and Options Prospectus

×

Cleansing and Options Prospectus

18 December 24

Cardiex Completes Placement Ahead of CONNEQT US Launch

×

Cardiex Completes Placement Ahead of CONNEQT US Launch

18 December 24

Proposed issue of securities - CDX

×

Proposed issue of securities - CDX

16 December 24

Trading Halt

×

Trading Halt

04 December 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

02 December 24

Application for quotation of securities - CDX

×

Application for quotation of securities - CDX

CDX Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.10 -0.13 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.10 -0.13 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -93.2 -26.6 74.1 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.08 -0.10 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.08 -0.08 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -157.0 -25.4 85.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -30.1 -59.8 -55.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.05 -0.00 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 -0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -36.8 -116.8 236.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 115 145 201 Lock Lock Lock
Basic m Lock Lock Lock Lock 115 145 201 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 4 5 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.7 13.2 136.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 6 8 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -7 -8 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -148.6 -22.2 98.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -170.4 -184.0 -0.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 270 284 101 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -12 -16 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -139.5 -29.9 61.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -307.0 -352.1 -57.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -13 -16 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -132.4 -29.4 60.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -312.4 -357.0 -60.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -12 -20 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -12 -19 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -128.0 -59.9 64.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -290.4 -410.2 -62.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -9 -12 -8 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 11 8 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -12 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -126.6 -25.6 35.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.4 -2.6 -0.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 1 7 5 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 12 15 13 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 1 -2 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 15 9 Lock Lock Lock
Equity $m Lock Lock Lock Lock 7 -1 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 7 0 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -17.6 -103.7 1,820.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -95.4 -129.9 -53.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -178.6 2,523.6 -165.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -140.4 -267.5 -113.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -154.6 -540.0 -314.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -120.1 -343.0 -359.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -54.8 -39.7 -5.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.1 0.1 0.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 10.3 296.6 -36.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.9 0.8 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.7 0.7 1.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 30.1 55.0 51.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -179.4 -81.1 -95.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.0 2.0 4.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 15.3 9.8 5.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 4.7 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 47.7 143.2 32.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.3 0.9 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.3 0.9 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -306.6 -425.9 -74.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -100.7 -134.9 -64.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -95.4 -129.9 -53.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.9 -19.4 3.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -178.6 2,523.6 -165.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -178.6 2,523.6 -165.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 23.9 37.1 69.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 123.1 180.0 79.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 147.0 217.1 149.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 42.9 113.3 155.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 104.0 103.8 -6.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CDX Shortsell

Frequently Asked Questions

The current share price of CardieX Limited (CDX:ASX) is AU$0.051.
The 52-week high share price for CardieX Limited (CDX:ASX) is AU$0.17.
The 52-week low share price for CardieX Limited (CDX:ASX)? is AU$0.05.
CardieX Limited (CDX:ASX) does not pay a dividend.
CardieX Limited (CDX:ASX) does not pay a dividend.
CardieX Limited (CDX:ASX) has a franking level of 0.0%.
CardieX Limited (CDX:ASX) is classified in the Healthcare.
The current P/E ratio for CardieX Limited (CDX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.